Table III.

Recognition of peptide and tumor before and after immunization: ELISPOT assay

PatientPreAfter Three or Four Courses
CIRA2 + peptideMelanomaCIRA2 + peptideMelanoma
02802095266248889380280209526624888938
(A2+)(A2+)(A2)(A2)(A2+)(A2+)(A2)(A2)
(Number spots/105 PBMC)
1242428710610108 290 a 414157
2108117115173 321 222958
3261726810512518 1160 432 227 1593
42117257915275261010 266 22030016163
51278937388 509 3404
6333047175595224 489 8937744
78462792112418241315 577 28411711150
82492314205853 507 9734069
93522175306820 710 4217024
1016151112141656748 636 105361967
115559111241510 782 299 334 3015
12121118111418111113 725 88143117
1313101313131842920 1486 219 234 5038
14555817201123 377 56523116
151399682010134 1474 613 574 2524
16201620202132353315 2082 627 773 4339
1789101131201863 831 113 165 2823
  • a Values twice both controls are underlined.